Severe hemoperitoneum due to endometriosis in a non-pregnant woman under dienogest therapy: a case report
article
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
This report details a severe hemoperitoneum in a non-pregnant woman with endometriosis on dienogest therapy, which was successfully treated via laparoscopy to achieve hemostasis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a chronic, estrogen-dependent, inflammatory disease that mainly affects women of reproductive age and is defined by the presence of endometrial glands and stroma at ectopic sites. Spontaneous hemoperitoneum due to bleeding of pelvic endometriotic foci represents a very rare and severe complication of endometriosis, although most cases described in literature regard pregnant women. We hereby present a case of a severe hemoperitoneum in a non-pregnant, 42 years old woman, under dienogest therapy for deep endometriosis. This life-threatening condition was promptly managed by performing an exploratory laparoscopy where the source of bleeding was found and hemostasis successfully achieved.Bleeding from pelvic endometriotic foci ought to be considered in the differential diagnosis of gynecological causes of acute abdomen and hemoperitoneum, even under medical therapy.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (7)
- A Very Rare Case of Endometriosis Presenting With Massive Hemoperitoneum via openalex
- Clinical diagnosis of endometriosis and optimal medical therapy via openalex
- Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma via openalex
- Massive haemoperitoneum from endometriosis masquerading as ruptured ectopic pregnancy: case report. via openalex
- Spontaneous hemoperitoneum in pregnancy (SHiP) and endometriosis — A systematic review of the recent literature via openalex
- The Effect of a Single Midcycle Administration of 0.5 or 2.0 mg Dienogest (17α-cyanomethyl- 17β-hydroxy-estra-4, 9-dien-3-one)on Pituitary and Ovarian Function - Investigation for the Use as a Postcoital Contraceptive<sup>1</sup>) via openalex
- W2412266915 via openalex
Cited by (3)
Source provenance
- europepmc
- last seen: 2026-08-07T06:07:27.085738+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:22:35.348889+00:00
License: CC0
· commercial use OK